SecBot SecBot
SECBOTREPLAY Home › Report › VIR

VIR · Vanina de Verneuil, an officer of Vir Biotechnology, filed a Form 144…

Vir Biotechnology, Inc. · 144 filed Nov 3, 2026 at 10:15 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 3, 2026 at 10:15 ET

Vanina de Verneuil, an officer of Vir Biotechnology, filed a Form 144 notice of intent to sell 2,407 shares of common stock, valued at approximately $26,718 based on the filing date price. The shares were acquired through restricted stock vesting on November 1, 2026. The proposed sale is small relative to the company's $2.0B market cap and appears to be a routine transaction to cover tax withholding or diversify holdings.

  • Officer Vanina de Verneuil filed Form 144 to sell 2,407 shares of Vir Biotechnology common stock.
  • Estimated aggregate value of the proposed sale is $26,717.70.
  • Shares were acquired on November 1, 2026 via restricted stock vesting from the issuer.
  • The sale is planned for execution on or after November 3, 2026 on Nasdaq.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access